OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!
Many cancer patients feel scared and overwhelmed after appointments, often seeking help online. This video explores the dangers of misinformation in cancer therapy, highlighting how some advice, while seemingly helpful, can be harmful. It emphasizes the critical need for reliable health advice and comprehensive patient education to ensure proper patient care. 🎯 What You’ll Learn in This Episode • What tele-oncology is and how it’s used • Why some programs may lack clinical depth • The difference between navigation and clinical decision-making • Why deeper testing may matter in cancer care • How to evaluate cancer guidance programs • What “precision oncology” should actually include • Why monitoring matters beyond imaging • Questions to ask before trusting a program 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com [https://www.envita.com/?utm_source=DrDinoPodcast] 📞 Speak with a care coordinator: 866-830-4576 “Not all guidance is equal — the right questions can protect your care.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493 [ https://www.scirp.org/journal/paperinformation?paperid=132493]
111 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!!